Page last updated: 2024-08-21

glycyrrhizic acid and Cancer of Colon

glycyrrhizic acid has been researched along with Cancer of Colon in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Afkhami-Poostchi, A; Iranshahi, M; Mashreghi, M; Matin, MM1
Khan, AQ; Khan, R; Rehman, MU; Sultana, S; Tahir, M1
Barczyk, M; Cichoń, T; Jarosz, M; Matuszczak, S; Smolarczyk, R; Szala, S1
Ehemann, V; Gdynia, G; Roth, W; Zhang, CC1
Cai, Q; Chen, X; Harris, RC; Kon, V; Pozzi, A; Shrubsole, MJ; Xu, J; Yao, B; Yin, H; Zhang, MZ; Zheng, W1

Other Studies

5 other study(ies) available for glycyrrhizic acid and Cancer of Colon

ArticleYear
Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model.
    International journal of pharmaceutics, 2020, Apr-15, Volume: 579

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Drug Delivery Systems; Escherichia coli; Genetic Engineering; Glucuronidase; Glycyrrhizic Acid; Male; Mice; Prodrugs; Tumor Microenvironment

2020
Glycyrrhizic acid suppresses 1,2-dimethylhydrazine-induced colon tumorigenesis in Wistar rats: Alleviation of inflammatory, proliferation, angiogenic, and apoptotic markers.
    Environmental toxicology, 2018, Volume: 33, Issue:12

    Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Apoptosis; Biomarkers; Carcinogenesis; Cell Proliferation; Colonic Neoplasms; Glycyrrhizic Acid; Inflammation; Male; Neovascularization, Physiologic; Rats; Rats, Wistar

2018
D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.
    Archivum immunologiae et therapiae experimentalis, 2014, Volume: 62, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Growth Processes; Colonic Neoplasms; Female; Glycyrrhizic Acid; Humans; Interleukin-12; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Peptide Fragments; Peptides; Recurrence; Skin Neoplasms; Time Factors; Tumor Burden

2014
The HMGB1 protein sensitizes colon carcinoma cells to cell death triggered by pro-apoptotic agents.
    International journal of oncology, 2015, Volume: 46, Issue:2

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Colonic Neoplasms; Glycyrrhizic Acid; HCT116 Cells; HMGB1 Protein; Humans; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Sulfonamides; TNF-Related Apoptosis-Inducing Ligand

2015
Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.
    The Journal of clinical investigation, 2009, Volume: 119, Issue:4

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adenocarcinoma; Adenoma; Animals; Base Sequence; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Gene Silencing; Genes, APC; Glycyrrhizic Acid; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Models, Biological; Neovascularization, Pathologic; Receptors, Glucocorticoid; RNA, Small Interfering

2009